Derivation and Validation of a Combination of BOSTON Score and DES-OSA Score for Selection of OSA Patients.
NCT ID: NCT03983564
Last Updated: 2022-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2021-09-01
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography
NCT01175031
Comparison of Preoperative Screening Score for Obstructive Sleep Apnea (OSA)
NCT02051829
Multidimensional System as Predictor of Outcomes in Obstructive Sleep Apnea: The OSA-SCORE
NCT01175421
Comparison of Demographic Data Mentioned by the Patients or Measured by a Physician
NCT05709964
Home Nasal Pressure for Sleep Apnea Management in Primary Case
NCT02141165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Firstly, the investigators will use a retrospective cohort of 400 patients to determine this combination. It will allow classifying patients in 3 groups: 1) patients for whom OSA can be excluded with certitude, 2) patients for whom OSA can be diagnosed with certitude, and 3) an intermediate group.
Secondly, the 100 patients included in this study will serve to validate the cutoff of the abovementioned combination into a new population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All patients
Patients in this group will serve to validate the cutoff of the combination of the DES-OSA and BOSTON scores derived in the retrospective group.
Cutoff Validation
We will validate the cutoff of the combination of BOSTON score and DES-OSA scores with the result of a polysomnography.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cutoff Validation
We will validate the cutoff of the combination of BOSTON score and DES-OSA scores with the result of a polysomnography.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric DEFLANDRE, MD, PhD, FCCP, FAHA
Head of Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Deflandre, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Clinique Saint-Luc of Bouge
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Saint-Luc de Bouge
Bouge, Namur, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PS-PSG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.